Vertex Pharmaceuticals Inc (VRTX)
450.37
-0.86
(-0.19%)
USD |
NASDAQ |
Nov 21, 16:00
449.00
-1.37
(-0.30%)
Pre-Market: 08:34
Vertex Pharmaceuticals Shares Outstanding: 257.53M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| October 31, 2024 | 257.53M |
| September 30, 2024 | 257.74M |
| July 31, 2024 | 258.10M |
| June 30, 2024 | 258.02M |
| April 30, 2024 | 258.05M |
| March 31, 2024 | 258.30M |
| March 18, 2024 | 258.46M |
| February 09, 2024 | 258.31M |
| December 31, 2023 | 257.70M |
| October 31, 2023 | 257.68M |
| September 30, 2023 | 257.83M |
| July 31, 2023 | 258.09M |
| June 30, 2023 | 257.79M |
| April 25, 2023 | 257.55M |
| March 31, 2023 | 257.51M |
| March 23, 2023 | 257.59M |
| January 31, 2023 | 257.09M |
| December 31, 2022 | 257.01M |
| October 21, 2022 | 256.69M |
| September 30, 2022 | 256.65M |
| July 29, 2022 | 256.46M |
| June 30, 2022 | 256.03M |
| April 29, 2022 | 255.76M |
| March 31, 2022 | 255.58M |
| March 24, 2022 | 255.53M |
| Date | Value |
|---|---|
| January 31, 2022 | 254.58M |
| December 31, 2021 | 254.48M |
| October 29, 2021 | 254.25M |
| September 30, 2021 | 256.21M |
| July 23, 2021 | 259.43M |
| June 30, 2021 | 259.11M |
| April 22, 2021 | 258.87M |
| March 31, 2021 | 258.83M |
| March 25, 2021 | 258.82M |
| January 31, 2021 | 259.96M |
| December 31, 2020 | 259.89M |
| October 23, 2020 | 260.04M |
| September 30, 2020 | 260.17M |
| July 23, 2020 | 260.47M |
| June 30, 2020 | 260.12M |
| April 24, 2020 | 259.28M |
| April 09, 2020 | 259.17M |
| March 31, 2020 | 259.08M |
| January 31, 2020 | 259.27M |
| December 31, 2019 | 258.99M |
| October 18, 2019 | 257.15M |
| September 30, 2019 | 257.26M |
| July 26, 2019 | 257.04M |
| June 30, 2019 | 256.67M |
| April 24, 2019 | 256.12M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
254.25M
Minimum
Oct 29 2021
260.47M
Maximum
Jul 23 2020
257.87M
Average
258.02M
Median
Jun 30 2024
Shares Outstanding Benchmarks
| Gilead Sciences Inc | 1.246B |
| Eli Lilly and Co | 949.32M |
| Bristol-Myers Squibb Co | 2.028B |
| Moderna Inc | 384.82M |
| Pfizer Inc | 5.667B |